Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Cipla Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (476)
Cancellation by sponsor (195)
Cancellation or suspension (77)
Prescription medicine registration (37)
Cancellation for failure to pay annual charge (17)
Australian Public Assessment Report (AusPAR) (4)
Prescription medicine decision summary (4)
Prescription medicine evaluation (1)

Date

2024 (73)
2023 (102)
2022 (74)
2021 (76)
2020 (120)
2019 (22)
2018 (69)
2017 (106)
2016 (31)
2015 (36)
2014 (21)
2013 (9)
2012 (5)
2011 (6)
2010 (20)
2009 (5)
2008 (3)
2007 (6)
2006 (7)
2005 (2)
2004 (2)
2003 (4)
2002 (3)
2001 (4)
2000 (1)
1999 (2)
1998 (1)
1996 (1)

Results for "[search-keyword]"

Search

Sponsor content

811 result(s) found, displaying 441 to 450

PHARMACY HEALTH FLUCONAZOLE 150mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PRICELINE PHARMACY FLUCONAZOLE 150mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PRICELINE LORATADINE loratadine 10mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PHARMACY HEALTH LORATADINE loratadine 10mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PHARMACY HEALTH THROAT NUMBING LOZENGES blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PRICELINE PHARMACY THROAT NUMBING LOZENGES blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
Suspended from ARTG - PHARMACY HEALTH REFLUX RELIEF EXTRA STRENGTH ranitidine 300mg (as hydrochloride) capsule-shaped tablet blister strip pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PHARMACY HEALTH IBUPROFEN + CODEINE film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
PRICELINE PHARMACY IBUPROFEN + CODEINE film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

24 June 2020

Cancellation by sponsor

Requested by Cipla Australia Pty Ltd
DEXEMCIP, DEXMED, DEXMEDETOMIDINE CIPLA (Cipla Australia Pty Ltd)

9 June 2020

Prescription medicine registration

Active ingredients: dexmedetomidine hydrochloride.

Pages

First page
Previous page
…
Page 41
Page 42
Page 43
Page 44
Current page 45
Page 46
Page 47
Page 48
Page 49
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.